10% > Inhibition >1 %
|
Cannabinoid CB1 receptor (Human) |
[3H]-CP-55,940 |
Human recombinant |
9.12 |
100 |
(R)-(+)-WIN55212-2 mesylate salt |
Cannabinoid CB2 receptor (Human) |
[3H]-CP-55,940 |
Human recombinant |
8.57 |
100 |
(R)-(+)-WIN55212-2 mesylate salt |
Serotonin 5HT2A receptor (Human) |
[3H]-Ketanserin hydrochloride |
Human recombinant |
8.32 |
100 |
Ketanserin tartrate salt |
Adenosine A3 receptor (Human) |
[125I]-AB-MECA |
Human recombinant |
8.22 |
99.41 |
IB-MECA |
Norepinephrine transporter (Human) |
[3H]-Nisoxetine hydrochloride |
Human recombinant |
7.89 |
99.13 |
Desipramine hydrochloride |
Bradykinin B2 receptor (Human) |
[3H]-Bradykinin |
Human recombinant |
7.88 |
94.95 |
HOE140 |
α2C-Adrenergic receptor (Human) |
[3H]-Rauwolscine hydrochloride |
Human recombinant |
7.75 |
100 |
Rauwolscine hydrochloride |
Monoamine transporter |
[3H]-α-Dihydrotetrabenazine |
Rabbit platelet |
7.73 |
100 |
Ketanserin tartrate salt |
Imidazoline receptor (Central) |
[3H]RX 781094(3H-Idazoxan) |
Rat cerebral cortex |
6.53 |
100 |
Guanabenz acetate salt |
Dopamine D3 receptor (Human) |
R-(+)-7-Hydroxy-[3H]DPAT |
Human recombinant |
6.32 |
100 |
(±)-7-Hydroxy-2-(di-n-propylamino)tetralin ((±)-7-OH-DPAT) |
Neurokinin NK2 receptor (Human) |
[3H]-SR 48968 |
Human recombinant |
6.12 |
99.61 |
Neurokinin A |
Bradykinin B1 receptor (Human) |
[3H]-Kallidin (Des-Arg 10, Leu 9) |
Human recombinant |
6.03 |
100 |
Lys-(des-Arg 9,Leu 8)-Bradykinin trifluoroacetate salt |
Opiate ORL1 receptor (Human) |
[3H]-Nociceptin |
Human recombinant |
5.76 |
100 |
Orphanin FQ |
Melatonin MT1 receptor (Human) |
[125I]-Melatonin |
Human recombinant |
5.74 |
100 |
Melatonin |
α1A-Adrenergic receptor |
[3H]-Prazosin |
Rat submandibular gland |
5.13 |
100 |
Prazosin hydrochloride |
K channel KA |
[125I]-Dendrotoxin |
Rat cerebral cortex |
5.11 |
99.78 |
α-Dendrotoxin |
Opiate κ receptor (Human) |
[3H]-Diprenorphine |
Human recombinant |
4.86 |
100 |
U-69593 |
Neurokinin NK3 receptor (Human) |
[125I]-Neurokinin B (N–Me-Phe 7) |
Human recombinant |
4.65 |
100 |
Succinyl-[Asp 6, N–Me-Phe 8]-Substance P Fragment 6–11(Senktide) |
Glutamate (NMDA polyamine site) |
[3H]-Ifenprodil |
Rat cerebral cortex |
3.79 |
99.68 |
Ifenprodil tartrate salt |
Neurokinin NK1 receptor (Human) |
[125I]-Substance P |
Human recombinant |
3.74 |
99.87 |
L-703,606 oxalate salt hydrate |
Endothelin ETB receptor (Human) |
[125I]-Endothelin-1 (Human, Porcine) |
Human recombinant |
3.39 |
95.1 |
Endothelin-1(Human) |
CCK B receptor (Human) |
[125I]-Cholecystokinin Octapeptide |
Human recombinant |
3.31 |
100 |
CCK-Octapeptide (26–33) (Sulfated Form) (CCK-8) |
α2B-Adrenergic receptor (Human) |
[3H]-Rauwolscine hydrochloride |
Human recombinant |
2.87 |
100 |
Rauwolscine hydrochloride |
Glutamate receptor (NMDAglycine site) |
[3H]-MDL105,519 |
Rat cerebral cortex |
2.56 |
100 |
MDL105,519 |
VIP 1 receptor (Human) |
[125I]-Vasoactive Intestinal Polypeptide |
Human receptor (Non-recombinant) |
2.48 |
100 |
Vasoactive Intestinal Peptide human, porcine, rat (VIP) |
K Channel SkCa |
[125I]-Apamin |
Rat whole brain |
2.36 |
100 |
Apamin |
Serotonin 5HT3 receptor (Human) |
[3H]-GR65630 |
Human recombinant |
2.21 |
95.14 |
MDL72222 |
K Channel KATP |
[3H]-Glybenclamide |
Rat whole brain |
2.08 |
100 |
Glibenclamide |
Adenosine A1 receptor (Human) |
[3H]8-Cyclopentyl-1,3-dipropylxanthine ([3H]-DPCPX) |
Human recombinant |
1.83 |
96.61 |
8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) |
α1B-Adrenergic receptor |
[3H]-Prazosin |
Rat liver |
1.76 |
100 |
Prazosin hydrochloride |
GABA A receptor (Benzodiazepine site) |
[3H]-Flunitrazepam |
Rat whole brain |
1.37 |
100 |
Diazepam |
Glutamate receptor (NMDA phencycidine site) |
[3H]-(+)-MK-801 |
Rat cerebral cortex |
1.27 |
100 |
(+)-MK-801 hydrogen maleate |
Ca Channel (Type L, Dihydropyridine) |
[3H]-PN200-110 |
Rat cerebral cortex |
1.17 |
100 |
Nitrendipine |
GABA B receptor |
gamma-[3H]-Aminobutyric Acid, ([3H]GABA) |
Rat cerebellum |
1.1 |
93.92 |
γ-Aminobutyric acid (GABA) |